Dataset from A Phase 1 Study to Estimate MMAE Metabolites in Human Plasma and Urine in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma or Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Receiving Brentuximab Vedotin
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007565
下载链接
链接失效反馈官方服务：
资源简介：
This is an open-label trial to estimate the concentrations of brentuximab vedotin in
relapsed/refractory Hodgkin lymphoma (HL) or relapsed/refractory systemic anaplastic large
cell lymphoma (sALCL) participants treated with either brentuximab vedotin or brentuximab
vedotin + rifampicin.
创建时间：
2025-10-21
